(888) 31-NDASA info@NDASA.com
  • Facebook
  • X
  • Instagram
  • RSS
  • Facebook
  • X
  • Instagram
  • RSS
  • NDASA
  • NDASA University
  • Member Login
0 Items
NDASA
  • About
    • About Us
    • Leadership
    • Professionals Directory
  • Training
    • Training Opportunities
    • NDASA University
      • My Courses
    • NDASA University Partner Program
    • Webinars
      • Webinar Library
    • Accreditation
    • Mentorship
    • Path to Trainer Excellence
  • Get involved
    • Committees
      • International Council
      • Community Outreach
    • Become a Trainer
    • State Affiliate Caucus
    • Our Federal PAC
    • Board of Directors
  • Join us
    • Become a Member
    • Member Benefits
    • Sponsorships & Advertising
    • Accreditation
    • Preferred Provider
  • News
    • Resources
  • Events
    • Calendar
    • 2026 Conference and Trade Show
    • 2025 Conference Highlights
    • Regional Training
  • Support
    • Sponsorships & Advertising
    • NDASA Foundation
  • Shop
  • Help
Select Page
NDASA’s response to proposed guidelines for Oral Fluid Testing and other changes to 49 CFR Part 40

NDASA’s response to proposed guidelines for Oral Fluid Testing and other changes to 49 CFR Part 40

by NDASA | Apr 26, 2022 | Advocacy, DOT, Drug & Alcohol Testing, NDASA Guidance

In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On April 20, NDASA...

Search this site

Stay in touch

  • Follow
  • Follow
  • Follow
  • Follow

Give to NDASA

Invest in safe and drug-free communities and workplaces and support NDASA.
Give now

Latest News & Updates

  • Oct 16, 2025From stadium tours to safer workplaces – what entertainers can teach us about program management
  • Oct 16, 20254 Things every employer should know about oral fluid testing
  • Oct 13, 2025NDASA submits comments on DOT proposal to add fentanyl to drug testing panel
  • Oct 07, 2025NDASA Announces 2026 Conferene Keynote Speaker: Dr. Stephen Loyd
  • Aug 19, 2025URGENT Take Action NOW on Rescheduling Marijuana

Topics We Track

  • Advocacy (15)
  • Business Development (7)
  • Committee Reports (1)
  • DOT (21)
  • Drug & Alcohol Testing (60)
  • Drug Legislation (17)
  • Feature (128)
  • FMCSA (7)
  • For Drug Testing Industry Professionals (24)
  • For Employers and Workplace Safety & Wellness Professionals (18)
  • Industry News (31)
  • Marijuana & CBD (24)
  • Member Benefits (4)
  • Membership (6)
  • MROs (3)
  • NDASA Conference (19)
  • NDASA Guidance (4)
  • NDASA News (4)
  • Newsletter Only (9)
  • Opioids (3)
  • Oral Fluid Testing (2)
  • Partners (1)
  • Resources (36)
  • Substance Use (5)
  • Substance Use/Addiction (10)
  • The Voice (7)
  • Training (5)
  • Uncategorized (30)
  • Workplace Safety (17)

  • From stadium tours to safer workplaces – what entertainers can teach us about program management
  • 4 Things every employer should know about oral fluid testing
  • NDASA submits comments on DOT proposal to add fentanyl to drug testing panel
  • NDASA Announces 2026 Conferene Keynote Speaker: Dr. Stephen Loyd
  • URGENT Take Action NOW on Rescheduling Marijuana

Legal Documents

  • Articles of Incorporation
  • Exemption Letter
  • IRS Designation Letter

NDASA Bylaws

  • Bylaws

Careers

Visit our job board

NDASA Policies

  • Privacy Policy
  • Security Policy
  • Refund Policy
  • Shipping Policy

Join the Newsletter

Proud Member of

Thank you to our sponsors

 

© 2023 National Drug and Alcohol Screening Association • All Rights Reserved • Web Powered by Media Salad